Use of randomised trials to decide when to monitor response to new treatment

被引：22

作者：

Bell, Katy J. L. ^{[1
]}

Irwig, Les ^{[1
]}

Craig, Jonathan C. ^{[1
]}

Macaskill, Petra ^{[1
]}

机构：

[1] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 336卷 / 7640期

关键词：

D O I：

10.1136/bmj.39476.623611.25

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：361 / 365

页数：9

共 11 条

[1] Monitoring osteoporosis therapy with bone densitometry - Misleading changes and regression to the man [J].

Cummings, SR ;

Palermo, L ;

Browner, W ;

Marcus, R ;

Wallace, R ;

Pearson, J ;

Blackwell, T ;

Eckert, S ;

Black, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1318-1321

[2] Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs [J].

Cummings, SR ;

Karpf, DB ;

Harris, F ;

Genant, HK ;

Ensrud, K ;

LaCroix, AZ ;

Black, DM .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :281-289

[3] Monitoring in chronic disease: a rational approach [J].

Glasziou, P ;

Irwig, L ;

Mant, D .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7492) :644-648

[4]

GLASZIOU P, 2007, EVIDENCE BASED MED M, P245

[5] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].

Grundy, SM ;

Cleeman, JI ;

Merz, CNB ;

Brewer, HB ;

Clark, LT ;

Hunninghake, DB ;

Pasternak, RC ;

Smith, SC ;

Stone, NJ .

CIRCULATION, 2004, 110 (02) :227-239

[6] The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials [J].

Moher, D ;

Schulz, KF ;

Altman, DG .

LANCET, 2001, 357 (9263) :1191-1194

[7] Regression to the mean: treatment effect without the intervention [J].

Morton, V ;

Torgerson, DJ .

JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2005, 11 (01) :59-65

[8] A CONSUMERS GUIDE TO SUBGROUP ANALYSES [J].

OXMAN, AD ;

GUYATT, GH .

ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :78-84

[9] Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension [J].

Sellin, Lorenz ;

Stegbauer, Johannes ;

Laeis, Petra ;

Rump, Lars C. .

JOURNAL OF HYPERTENSION, 2005, 23 (11) :2083-2092

[10] Individual therapy: New dawn or false dawn? [J].

Senn, S .

DRUG INFORMATION JOURNAL, 2001, 35 (04) :1479-1494

← 1 2 →